The pharmaceutical industry is rapidly changing with the growing popularity of biologics and biosimilars. In fact, more than 60 percent of patent filings are made on behalf of the industry’s… Read More »
“Device manufacturers and stakeholders, including biopharma companies, healthcare providers, payers and patients, have realised the benefits and importance of training prior to initial self-injections, continuous training and onboarding throughout disease… Read More »
Although there are many positive changes impacting self-injecting patients, there are also some challenges patients and other stakeholders face, including training decay from lengthy gaps between self-administration, forgetfulness… Read More »
Pulmonary drug delivery is one of the most common routes of administration for chronic and acute conditions, such as chronic obstructive pulmonary disease (COPD) and severe asthma. As with… Read More »
Poor patient compliance and adherence cost the healthcare system more than $564 billion annually. It is important that pharmaceutical brands and healthcare providers (HCPs) leverage technology to help reduce primary… Read More »
Noble®, the biopharma onboarding and device training leader, today announces its new Smart Injection Pad, engineered with the latest in multisensory and error correcting technologies. A recent study from the… Read More »